3-compartment dynamic model of talaporfin sodium pharmacokinetics in silico

Emiyu Ogawa, Yuko Uno, Keishi Ohtani, Sachio Maehara, Kentaro Imai, Shotaro Ono, Jitsuo Usuda, Tsunenori Arai

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

We studied a 3-compartment dynamic model of talaporfin sodium pharmacokinetics in silico. Drug distribution might change after intravenous injection from plasma to interstitial space and then into myocardial cells. We have developed a new cardiac ablation using photosensitization reaction with laser irradiation shortly after talaporfin sodium injection. We think that the major cell-killing factor in our cardiac ablation would be an oxidation by singlet oxygen produced in the interstitial space in myocardium with laser irradiation shortly after the photosensitizer administration. So that the talaporfin sodium concentration change in time in the interstitial space should be investigated. We constructed the pharmacokinetics dynamic model composed by 3-compartments, that is, plasma, interstitial space, and cell. We measured talaporfin sodium fluorescence time change in human skin by our developed fluorescence measurement system in vivo. Using the measured concentration data in plasma and skin in human, we verified the calculation accuracy of our in silico model. We compared the simulated transition tendency of talaporfin sodium concentration from interstitial space to cells in our in silico model with the reported uptake tendency using cultured myocardial cell. We identified the transition coefficients between plasma, interstitial space, and cell compartment, and metabolization coefficient from plasma by the fitting with measured data.

Original languageEnglish
Title of host publicationOptical Methods for Tumor Treatment and Detection
Subtitle of host publicationMechanisms and Techniques in Photodynamic Therapy XXVI
PublisherSPIE
Volume10047
ISBN (Electronic)9781510605350
DOIs
Publication statusPublished - 2017
EventOptical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXVI - San Francisco, United States
Duration: 2017 Jan 282017 Jan 29

Other

OtherOptical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXVI
CountryUnited States
CitySan Francisco
Period17/1/2817/1/29

Fingerprint

Pharmacokinetics
compartments
dynamic models
Computer Simulation
Dynamic models
interstitials
Sodium
sodium
Plasmas
cells
Laser beam effects
Ablation
Skin
Lasers
ablation
Fluorescence
tendencies
Photosensitivity Disorders
Singlet Oxygen
Photosensitizing Agents

Keywords

  • 3-compartment model
  • NPe6
  • Pharmacokinetics
  • simulation

ASJC Scopus subject areas

  • Atomic and Molecular Physics, and Optics
  • Electronic, Optical and Magnetic Materials
  • Biomaterials
  • Radiology Nuclear Medicine and imaging

Cite this

Ogawa, E., Uno, Y., Ohtani, K., Maehara, S., Imai, K., Ono, S., ... Arai, T. (2017). 3-compartment dynamic model of talaporfin sodium pharmacokinetics in silico. In Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXVI (Vol. 10047). [100470Y] SPIE. https://doi.org/10.1117/12.2250716

3-compartment dynamic model of talaporfin sodium pharmacokinetics in silico. / Ogawa, Emiyu; Uno, Yuko; Ohtani, Keishi; Maehara, Sachio; Imai, Kentaro; Ono, Shotaro; Usuda, Jitsuo; Arai, Tsunenori.

Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXVI. Vol. 10047 SPIE, 2017. 100470Y.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Ogawa, E, Uno, Y, Ohtani, K, Maehara, S, Imai, K, Ono, S, Usuda, J & Arai, T 2017, 3-compartment dynamic model of talaporfin sodium pharmacokinetics in silico. in Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXVI. vol. 10047, 100470Y, SPIE, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXVI, San Francisco, United States, 17/1/28. https://doi.org/10.1117/12.2250716
Ogawa E, Uno Y, Ohtani K, Maehara S, Imai K, Ono S et al. 3-compartment dynamic model of talaporfin sodium pharmacokinetics in silico. In Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXVI. Vol. 10047. SPIE. 2017. 100470Y https://doi.org/10.1117/12.2250716
Ogawa, Emiyu ; Uno, Yuko ; Ohtani, Keishi ; Maehara, Sachio ; Imai, Kentaro ; Ono, Shotaro ; Usuda, Jitsuo ; Arai, Tsunenori. / 3-compartment dynamic model of talaporfin sodium pharmacokinetics in silico. Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXVI. Vol. 10047 SPIE, 2017.
@inproceedings{c9c9f5f6ab2449c48471a63da7aa4706,
title = "3-compartment dynamic model of talaporfin sodium pharmacokinetics in silico",
abstract = "We studied a 3-compartment dynamic model of talaporfin sodium pharmacokinetics in silico. Drug distribution might change after intravenous injection from plasma to interstitial space and then into myocardial cells. We have developed a new cardiac ablation using photosensitization reaction with laser irradiation shortly after talaporfin sodium injection. We think that the major cell-killing factor in our cardiac ablation would be an oxidation by singlet oxygen produced in the interstitial space in myocardium with laser irradiation shortly after the photosensitizer administration. So that the talaporfin sodium concentration change in time in the interstitial space should be investigated. We constructed the pharmacokinetics dynamic model composed by 3-compartments, that is, plasma, interstitial space, and cell. We measured talaporfin sodium fluorescence time change in human skin by our developed fluorescence measurement system in vivo. Using the measured concentration data in plasma and skin in human, we verified the calculation accuracy of our in silico model. We compared the simulated transition tendency of talaporfin sodium concentration from interstitial space to cells in our in silico model with the reported uptake tendency using cultured myocardial cell. We identified the transition coefficients between plasma, interstitial space, and cell compartment, and metabolization coefficient from plasma by the fitting with measured data.",
keywords = "3-compartment model, NPe6, Pharmacokinetics, simulation",
author = "Emiyu Ogawa and Yuko Uno and Keishi Ohtani and Sachio Maehara and Kentaro Imai and Shotaro Ono and Jitsuo Usuda and Tsunenori Arai",
year = "2017",
doi = "10.1117/12.2250716",
language = "English",
volume = "10047",
booktitle = "Optical Methods for Tumor Treatment and Detection",
publisher = "SPIE",

}

TY - GEN

T1 - 3-compartment dynamic model of talaporfin sodium pharmacokinetics in silico

AU - Ogawa, Emiyu

AU - Uno, Yuko

AU - Ohtani, Keishi

AU - Maehara, Sachio

AU - Imai, Kentaro

AU - Ono, Shotaro

AU - Usuda, Jitsuo

AU - Arai, Tsunenori

PY - 2017

Y1 - 2017

N2 - We studied a 3-compartment dynamic model of talaporfin sodium pharmacokinetics in silico. Drug distribution might change after intravenous injection from plasma to interstitial space and then into myocardial cells. We have developed a new cardiac ablation using photosensitization reaction with laser irradiation shortly after talaporfin sodium injection. We think that the major cell-killing factor in our cardiac ablation would be an oxidation by singlet oxygen produced in the interstitial space in myocardium with laser irradiation shortly after the photosensitizer administration. So that the talaporfin sodium concentration change in time in the interstitial space should be investigated. We constructed the pharmacokinetics dynamic model composed by 3-compartments, that is, plasma, interstitial space, and cell. We measured talaporfin sodium fluorescence time change in human skin by our developed fluorescence measurement system in vivo. Using the measured concentration data in plasma and skin in human, we verified the calculation accuracy of our in silico model. We compared the simulated transition tendency of talaporfin sodium concentration from interstitial space to cells in our in silico model with the reported uptake tendency using cultured myocardial cell. We identified the transition coefficients between plasma, interstitial space, and cell compartment, and metabolization coefficient from plasma by the fitting with measured data.

AB - We studied a 3-compartment dynamic model of talaporfin sodium pharmacokinetics in silico. Drug distribution might change after intravenous injection from plasma to interstitial space and then into myocardial cells. We have developed a new cardiac ablation using photosensitization reaction with laser irradiation shortly after talaporfin sodium injection. We think that the major cell-killing factor in our cardiac ablation would be an oxidation by singlet oxygen produced in the interstitial space in myocardium with laser irradiation shortly after the photosensitizer administration. So that the talaporfin sodium concentration change in time in the interstitial space should be investigated. We constructed the pharmacokinetics dynamic model composed by 3-compartments, that is, plasma, interstitial space, and cell. We measured talaporfin sodium fluorescence time change in human skin by our developed fluorescence measurement system in vivo. Using the measured concentration data in plasma and skin in human, we verified the calculation accuracy of our in silico model. We compared the simulated transition tendency of talaporfin sodium concentration from interstitial space to cells in our in silico model with the reported uptake tendency using cultured myocardial cell. We identified the transition coefficients between plasma, interstitial space, and cell compartment, and metabolization coefficient from plasma by the fitting with measured data.

KW - 3-compartment model

KW - NPe6

KW - Pharmacokinetics

KW - simulation

UR - http://www.scopus.com/inward/record.url?scp=85019237923&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019237923&partnerID=8YFLogxK

U2 - 10.1117/12.2250716

DO - 10.1117/12.2250716

M3 - Conference contribution

VL - 10047

BT - Optical Methods for Tumor Treatment and Detection

PB - SPIE

ER -